In one paragraphArticle in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Mostefa FodilLaboratoire Biologie des Organismes, Stress, Santé, Environnement (BiOSSE), Faculté des Sciences et Techniques, Le Mans Université, Avenue Olivier Messiaen, F-72085 Le Mans, France.ORCID 0000-0003-2856-1988 Javier Muñoz-GarciaNantes Université, Centre National de la recherche Scientifique CNRS, UMR 6286, US2B, F-44322 Nantes, France.ORCID 0000-0002-2978-1192 Amel-Khitem BenaliLaboratoire Biologie des Organismes, Stress, Santé, Environnement (BiOSSE), Faculté des Sciences et Techniques, Le Mans Université, Avenue Olivier Messiaen, F-72085 Le Mans, France.
Jasmina RogozarskiUniversité Paris Cité, Therapeutic Optimization in Neuropharmacology, INSERM 1144, F-75006 Paris, France.
Virginie MignonUniversité Paris Cité, Cellular and Molecular Imaging Facility, US25 INSERM, UMS3612 CNRS, F-75006 Paris, France.
Honora LabranaUniversité Paris Cité, Therapeutic Optimization in Neuropharmacology, INSERM 1144, F-75006 Paris, France.
Anna LokajczykUniversité Paris Cité, Therapeutic Optimization in Neuropharmacology, INSERM 1144, F-75006 Paris, France.
Pamela PasettoInstitut des Molécules et Matériaux du Mans (IMMM), UMR CNRS 6283, Le Mans Université, Avenue Olivier Messiaen, F-72085 Le Mans, France.ORCID 0000-0003-2209-8080 Jean-Luc MougetLaboratoire Biologie des Organismes, Stress, Santé, Environnement (BiOSSE), Faculté des Sciences et Techniques, Le Mans Université, Avenue Olivier Messiaen, F-72085 Le Mans, France.
Catherine Boisson-VidalUniversité Paris Cité, Therapeutic Optimization in Neuropharmacology, INSERM 1144, F-75006 Paris, France.ORCID 0000-0001-6651-4926 Dominique HeymannNantes Université, Centre National de la recherche Scientifique CNRS, UMR 6286, US2B, F-44322 Nantes, France.ORCID 0000-0001-7777-0669 Funding
European Commission 734708/GHaNA/H2020-MSCA-RISE-2016
6 · The paper itselfAbstract
Angiogenesis is a fundamental biological process involved in the formation of new blood vessels from the pre-existing vascular network. In addition to physiological processes, angiogenesis is also implicated in pathological conditions such as tumour growth and metastatic progression. Research on marennine, a water-soluble blue-green pigment produced by the marine diatom
Indexed as
Angiogenesis InhibitorsCell ProliferationDiatomsNeoplasmsNeovascularization, PathologicAngiogenesisAnimalsApoptosisCell Line, TumorCell MovementHumansAngiogenesis Inhibitorsangiogenesis inhibitorsanticancer activityendothelial colony-forming cellsHaslea ostreariamarennine
Identifiers
PMID41003335
PMCPMC12471528
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390